Competition and Mkts - Merger Update: Intersurgical / Teleflex

Teleflex Incorporated

Tue 10:00

		
		
		
		
		
	
	
RNS Number : 1142Z
  
Competition and Markets Authority
  
20 October 2026
  
 

		

			

				Invitation to Comment: Anticipated acquisition by Intersurgical AG of the acute care and interventional urology businesses of Teleflex Incorporated, following which control over Intersurgical AG will be acquired by Armira Capital and TA Associates
			
			

				The CMA is issuing this ‘invitation to comment’ to allow interested parties to submit to the CMA any initial views on the impact that the transaction could have on competition in the UK. The CMA has not yet launched its formal investigation into this transaction. This invitation to comment is the first part of the CMA’s information-gathering process
			
			

				Invitation to comment: closes 3 November 2026
			
			

				To assist it with this assessment, the CMA invites comments on competition issues from any interested party.
			
			

				These comments should be provided by the deadline set out above to:
			
			

				Lucy Peckham
			
			

				lucy.peckham@cma.gov.uk
			
			

				AND
			
			

				Intersurgical.Teleflex@cma.gov.uk
			
			

				Your name and contact details are your personal data. In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please see our Privacy Notice.
			
			

				 
			
		
	
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MERMABRTMTJBMPF